Michael E.  Sturmer net worth and biography

Michael Sturmer Biography and Net Worth

President of Progyny
Michael brings to Progyny two decades of operations, sales and strategic experience within multiple facets of the healthcare industry. Michael was most recently SVP Health Services at Livongo where he led the development and growth of their health services business, a key part of Livongo’s exponential growth from pre-IPO to their acquisition by Teladoc for over $18.5 billion. Michael has also held senior leadership positions at Cigna including Chief Operating Officer for the New York/New Jersey Health Plan as well as roles in Consumer Health Engagement, Analytics, Technology, and National Accounts.

What is Michael E. Sturmer's net worth?

The estimated net worth of Michael E. Sturmer is at least $5.34 million as of July 16th, 2024. Mr. Sturmer owns 362,583 shares of Progyny stock worth more than $5,344,473 as of December 18th. This net worth estimate does not reflect any other investments that Mr. Sturmer may own. Additionally, Mr. Sturmer receives an annual salary of $836,490.00 as President at Progyny. Learn More about Michael E. Sturmer's net worth.

How old is Michael E. Sturmer?

Mr. Sturmer is currently 47 years old. There are 4 older executives and no younger executives at Progyny. The oldest executive at Progyny is Mr. David J. Schlanger, Executive Chairman, who is 65 years old. Learn More on Michael E. Sturmer's age.

What is Michael E. Sturmer's salary?

As the President of Progyny, Inc., Mr. Sturmer earns $836,490.00 per year. The highest earning executive at Progyny is Mr. Peter Anevski, CEO & Director, who commands a salary of $1,090,000.00 per year. Learn More on Michael E. Sturmer's salary.

How do I contact Michael E. Sturmer?

The corporate mailing address for Mr. Sturmer and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]. Learn More on Michael E. Sturmer's contact information.

Has Michael E. Sturmer been buying or selling shares of Progyny?

Michael E. Sturmer has not been actively trading shares of Progyny in the last ninety days. Most recently, Michael E. Sturmer sold 9,030 shares of the business's stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $30.00, for a transaction totalling $270,900.00. Following the completion of the sale, the president now directly owns 362,583 shares of the company's stock, valued at $10,877,490. Learn More on Michael E. Sturmer's trading history.

Who are Progyny's active insiders?

Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (Executive Chairman), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.

Are insiders buying or selling shares of Progyny?

In the last twelve months, insiders at the sold shares 17 times. They sold a total of 394,285 shares worth more than $14,787,337.29. The most recent insider tranaction occured on July, 16th when President Michael E Sturmer sold 9,030 shares worth more than $270,900.00. Insiders at Progyny own 12.3% of the company. Learn More about insider trades at Progyny.

Information on this page was last updated on 7/16/2024.

Michael E. Sturmer Insider Trading History at Progyny

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/16/2024Sell9,030$30.00$270,900.00362,583View SEC Filing Icon  
5/1/2024Sell4,515$31.95$144,254.25380,038View SEC Filing Icon  
4/1/2024Sell6,395$37.60$240,452.00384,553View SEC Filing Icon  
2/6/2024Sell2,260$40.00$90,400.00158,532View SEC Filing Icon  
1/2/2024Sell6,395$36.81$235,399.95167,187View SEC Filing Icon  
12/1/2023Sell12,696$34.13$433,314.48173,806View SEC Filing Icon  
See Full Table

Michael E. Sturmer Buying and Selling Activity at Progyny

This chart shows Michael E Sturmer's buying and selling at Progyny by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Progyny Company Overview

Progyny logo
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Read More

Today's Range

Now: $14.74
Low: $14.68
High: $15.30

50 Day Range

MA: $15.48
Low: $13.67
High: $17.18

2 Week Range

Now: $14.74
Low: $13.39
High: $42.08

Volume

1,284,062 shs

Average Volume

1,402,901 shs

Market Capitalization

$1.26 billion

P/E Ratio

25.41

Dividend Yield

N/A

Beta

1.35